G&S Capital LLC lowered its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 57.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,166 shares of the company's stock after selling 17,717 shares during the period. G&S Capital LLC's holdings in Procter & Gamble were worth $1,931,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Diversified Management Inc. increased its holdings in shares of Procter & Gamble by 3.8% during the second quarter. Diversified Management Inc. now owns 4,443 shares of the company's stock valued at $651,000 after purchasing an additional 161 shares during the period. Charles Schwab Trust Co lifted its holdings in Procter & Gamble by 5.8% in the second quarter. Charles Schwab Trust Co now owns 7,282 shares of the company's stock worth $1,068,000 after purchasing an additional 400 shares during the period. Salvus Wealth Management LLC grew its position in Procter & Gamble by 10.8% in the 2nd quarter. Salvus Wealth Management LLC now owns 3,942 shares of the company's stock valued at $578,000 after buying an additional 384 shares in the last quarter. Spinnaker Investment Group LLC grew its position in Procter & Gamble by 1.4% in the 2nd quarter. Spinnaker Investment Group LLC now owns 6,230 shares of the company's stock valued at $914,000 after buying an additional 83 shares in the last quarter. Finally, Affiance Financial LLC increased its stake in Procter & Gamble by 31.4% during the 2nd quarter. Affiance Financial LLC now owns 3,481 shares of the company's stock valued at $510,000 after buying an additional 832 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G’s beauty business is emerging as an important growth driver, supporting optimism that innovation and premium personal-care products can supplement the company’s mature portfolio. The company has also extended its dividend-increase streak to 70 consecutive years, reinforcing its appeal to income-focused investors. 188-year-old Dividend King just unlocked unexpected growth engine
- Positive Sentiment: Analysts at Erste Group project fiscal 2028 EPS of $7.42 and fiscal 2027 EPS of $7.00, broadly in line with the current consensus for fiscal 2027. The company’s latest quarterly results also included an EPS beat, while its strong cash generation continues to support dividends and share repurchases. Procter & Gamble analyst estimates
- Positive Sentiment: Investors continue to highlight PG as a defensive, long-term income stock because of its strong brands, resilient consumer demand, and shareholder-friendly capital allocation. The seasonal Old Spice Fallidudes launch also provides a modest product and marketing catalyst, though its financial impact is likely limited. Old Spice Fallidudes collection
- Neutral Sentiment: Articles explaining how many shares are needed to generate $10,000 in annual dividends underscore PG’s reliable income profile, but also suggest that achieving that payout requires a substantial investment at the current share price. Shares needed for $10,000 in dividends
- Negative Sentiment: Valuation remains a concern: PG trades at roughly 22 times earnings, while recent revenue came in below expectations despite an EPS beat. Its muted year-to-date and one-year total returns may be limiting investor enthusiasm for a premium-priced defensive stock.
- Negative Sentiment: Argus downgraded Procter & Gamble to “Hold,” adding a cautious signal. Erste Group also trimmed its fiscal 2027 EPS forecast slightly from $7.01 to $7.00, although the change is too small to materially alter the outlook. Argus cuts Procter & Gamble to Hold
Procter & Gamble Trading Down 0.8%
Shares of NYSE PG opened at $145.21 on Wednesday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The company has a market cap of $337.52 billion, a price-to-earnings ratio of 21.93, a P/E/G ratio of 4.51 and a beta of 0.39. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. The business has a fifty day simple moving average of $148.07 and a 200-day simple moving average of $149.00.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping analysts' consensus estimates of $1.41 by $0.02. The firm had revenue of $21.20 billion for the quarter, compared to analysts' expectations of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.Procter & Gamble's revenue was up 1.5% on a year-over-year basis. During the same quarter last year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Sell-side analysts predict that Procter & Gamble Company will post 6.99 EPS for the current year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, August 17th. Stockholders of record on Friday, July 24th will be given a $1.0885 dividend. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend is Friday, July 24th. Procter & Gamble's dividend payout ratio (DPR) is 65.71%.
Wall Street Analyst Weigh In
A number of analysts have commented on PG shares. HSBC restated a "hold" rating and set a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $163.00 price objective on shares of Procter & Gamble in a research note on Monday, April 27th. Morgan Stanley cut their target price on Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating for the company in a research report on Wednesday, April 22nd. Barclays increased their price target on Procter & Gamble from $146.00 to $152.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. Finally, Bank of America lowered their price target on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating on the stock in a research report on Friday, July 10th. Thirteen investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $161.52.
View Our Latest Stock Analysis on PG
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.